Sep 17
2019
Phanes and Hanmi announce licensing agreement to develop bi- and/or multi-specific antibodies
Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research in immuno-oncology announced today that it has signed a...
Read More
Jul 24
2019
Merck to provide BioReliance® End-to-End Solutions to Phanes Therapeutics
Collaboration to accelerate development and manufacturing of Bispecific Antibody Merck plans to offer Phanes a full suite of products and...
Read More
Mar 13
2018
CrownBio enters strategic partnership with Phanes Therapeutics to accelerate discovery and development of Phanes’ novel oncology agents
Original link: https://blog.crownbio.com/press/partnership-with-phanes (San Diego, Calif., March 13, 2018) — Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:...
Read More
Dec 14
2017
WuXi Biologics and Phanes announce strategic partnership
Shanghai and San Diego, Dec. 14, 2017 — WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering...
Read More
